Author:
Morris Don G.,Feng Xiaolan,DiFrancesco Lisa M.,Fonseca Kevin,Forsyth Peter A,Paterson Alexander H.,Coffey Matt C.,Thompson Brad
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference41 articles.
1. Dock G (1904) Rabies virus vaccintion in a patient with cervical carcinoma. Amer J Med Sci 127:563
2. Deweese TL, Van Der Poel H, Li SD, Mikhak B, Drew R, Goemann M, Hamper U, Dejong R, Detorie N, Rodriguez R, Haulk T, Demarzo AM, Piantadosi S, Yu DC, Chen Y, Henderson DR, Carducci MA, Nelson WG, Simons JW (2001) A phase I trial of Cv706, a replication-competent, Psa selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation Therapy. Cancer Res 61:7464–7472
3. Pecora AL, Rizvi N, Cohen GI, Meropol NJ, Sterman D, Marshall JL, Goldberg S, Gross P, O’neil JD, Groene WS, Roberts MS, Rabin H, Bamat MK, Lorence RM (2002) Phase I trial of intravenous administration of Pv701, an oncolytic virus, in patients with advanced solid cancers. J Clin Oncol 20:2251–2266
4. Vasey PA, Shulman LN, Campos S, Davis J, Gore M, Johnston S, Kirn DH, O’neill V, Siddiqui N, Seiden MV, Kaye SB (2002) Phase I trial of intraperitoneal injection of the E1b-55-Kd-Gene—deleted adenovirus Onyx-015 (Dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer. J Clin Oncol 20:1562–1569
5. Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, Kracher J, Grossman SA, Fisher JD, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, Nabors LB, Brem S, Phuphanich S, Freeman S, Kaplan R, Zwiebel J (2004) A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1b-attenuated adenovirus, Onyx-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther 10:958–966
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献